Drug Development

Precision Medicine Monotherapy Antiviral Therapies Treatment Options FDA Approval Anti-Ageing Drugs Drug Repurposing Cancer Research Antiviral Strategies GLP-1 Drugs

3 ARTICLES

last wk.

Fulcrum to Merge With Slate Medicines and Rebrand After FDA Safety Flags

The all‑stock deal and a $245 million financing give the combined company a new lead migraine antibody and the cash to advance it through mid‑stage trials.

4 ARTICLES

3mo ago

University of Basel Engineers First All-Human Bone Marrow Model That Sustains Blood Production

3 ARTICLES

11mo ago

Scripps Maps Human Proteins SARS-CoV-2 Exploits, Identifying Drug Targets With Preclinical Support

4 ARTICLES

last yr.

Researchers Develop mRNA-Based Therapy for Pre-Eclampsia in Mice

11 ARTICLES

2y ago

New Anti-Inflammatory Treatment Extends Lifespan in Mice by 25%

3 ARTICLES

2y ago

No New Information Available

Drug Development

Fulcrum to Merge With Slate Medicines and Rebrand After FDA Safety Flags

Hybrid Quantum Effort Simulates 12,635-Atom Protein Complexes

Study Identifies tRNA‑Modifying Enzymes as Broad Coronavirus Antiviral Targets

GLP-1 Weight-Loss Drugs Limit Heart Attack Damage in Mouse Study

J&J Beats Q4 Forecasts and Sets 2026 Guidance Above Wall Street

University of Basel Engineers First All-Human Bone Marrow Model That Sustains Blood Production

Scripps Maps Human Proteins SARS-CoV-2 Exploits, Identifying Drug Targets With Preclinical Support

Researchers Develop mRNA-Based Therapy for Pre-Eclampsia in Mice

New Anti-Inflammatory Treatment Extends Lifespan in Mice by 25%

No New Information Available